Sight Sciences saw the highest growth of 0.99% in patent filings and 0.49% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and grants by 0.49%. GlobalData’s DataBook provides a comprehensive analysis of Sight Sciences’s patent filings and grants. Buy the databook here.
Sight Sciences has been focused on protecting inventions in United States(US) with two publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 33% filings and 100% grants. The United States(US), European Patent Office(EPO), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where Sight Sciences is filings its patents. Among the top granted patent authorities, Sight Sciences has 100% of its grants in United States(US).
AbbVie and Alcon could be the strongest competitors for Sight Sciences
In terms of grant share, Sight Sciences stands in sixth position among its competitors. AbbVie and Alcon secured the top positions according to recent patent publication data.
Ophthalmic devices related patents lead Sight Sciences portfolio followed by glaucoma, and keratoconjunctivitis sicca (dry eye)
Sight Sciences has highest number of patents in ophthalmic devices followed by glaucoma, keratoconjunctivitis sicca (dry eye). For ophthalmic devices, nearly 33% of patents were filed and 100% of patents were granted in Q2 2024.
For comprehensive analysis of Sight Sciences's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.